The Velcade Three
Article: A hopeful decision from NICE
We, “The Velcade Three”, welcome the news of NICE's (National Institute for Health and Clinical Excellence) revised preliminary positive guidance which recommends that Velcade is made available on the NHS to some patients with multiple myeloma.
Last August NICE issued an negative decision that would deny patients access to a treatment that would give hope. However after 10 long months of campaigning against that decision which has resulted in a successful appeal, we now feel that the road ahead is more positive. We feel we have been given a second bite of the cherry to ensure us patients get the treatment we need.
The outcome we now need to see is that Velcade is made available to all myeloma sufferers at the point of need after consultation with their consultants and that there is no discrimination of patients in any way.
Copyright © The Velcade Three, 2010.